Archives: Agenda

Shark Tank

Each company will provide a 1-minute elevator pitch to showcase their innovations. 

Companies include: 

HIYA Labs, Natuera, Pixotine, VYE 

Moderator: Christopher C Barkauskas, Founder, CB Capital Advisory 

Speaker Hosted Roundtables

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

Each roundtable session lasts for 40 minutes, and delegates may attend up to 2 roundtables.

Roundtable 1: Innovation in Synthetic Nicotine

  • Innovation in high-purity synthetic (S)-nicotine
  • Moving away from tobacco by providing a “cleaner” nicotine alternative
  • Exploring next-generation products

Anand Ashok, Chief Executive Officer, Zanoprima Lifesciences

Derek Yach MBCHB MPH, Independent Global Health Consultant, Global Health Strategies LLC.

 

Roundtable 2:

  • Topic A – “Aligning Nicotine Policy & Communication to Reduce Misperceptions”

 Cheryl Olson, PhD, Regulatory Scientist, Womble Bond Dickinson (US) LLP   

  • Topic B – “Communicating THR: Bridging Science and Public Understanding”

Tiffany Parms, Senior Manager, Scientific & Public Health Affairs, Reynolds American Inc. (RAI) Services Company 

 

Roundtable 3: How Fast, Accurate Measurement is Redefining Next-Gen Tobacco Operations

  • How manufacturers are closing the gap between laboratory analysis and real-time production decisions
  • When rapid measurement accelerates decisions — and when it introduces risk
  • What leaders wish they had known before deploying faster measurement tools

Lynda Eisenmann, Senior Applications Engineer, Nordson MCS

Heather Lemieux, Senior Account Manager, Nordson MCS

Rest of the world – identifying opportunities for growth

  • Identifying growth opportunities outside of the US
  • Key regulatory developments and considerations
  • Ban on disposable vapes – lessons learnt and migrating to new and innovative products
  • Consumer trends and preferences in key international markets
  • EU Regulation – The EU has banned flavored heated tobacco, how will pouches be regulated in the future?
  • Smoking cessation by using nicotine alternatives

The Next Chapter of THR: What the Last 10 Years Taught Us, and what the next few years demand

  • A veteran of the “Tobacco Wars” who long championed sensible public health measures reflects on the first decade of Tobacco Harm Reduction: what we got right, what we underestimated, and what the next few years demand.
  • Significant progress has been made, with an estimated 129 million adults worldwide now using nicotine vaping products.
  • Yet misinformation and misunderstanding about nicotine and relative risk—including among physicians and other health professionals—remain widespread and continue to impede progress.
  • Despite ongoing disagreements, stakeholders should align around a three-part framework to advance THR and support the nearly 30 million adults in the United States who still smoke: (1) a robust, well-regulated marketplace for reduced-risk nicotine products; (2) strong enforcement against companies that evade product regulation, undermining both public trust and responsible industry actors; and (3) continued vigilance to prevent youth use of all tobacco and nicotine products.